Understanding Fat Tissue as a Source of Healing Cells
Carlo Tremolada, Valeria Colombo, Carlo Ventura · Current Stem Cell Reports · 2016
Fat Contains 1,000 Times More Stem Cells Than Bone Marrow
Your body's fat tissue is a surprisingly rich source of regenerative cells. Research shows that one in every 100 fat cells is a mesenchymal stem cell (MSC), a type of cell that helps repair damaged tissue. In comparison, bone marrow contains only one MSC for every 100,000 cells. This makes fat tissue an ideal source for regenerative treatments. Harvesting fat is also much simpler and less painful than extracting bone marrow.
These Healing Cells Work Like "Mini-Drugstores"
MSCs do more than just become new tissue. Scientists now understand they act as natural pharmacies inside your body. These cells release many healing substances that:
Reduce inflammation
Support new blood vessel growth
Protect cells from dying
Help regulate your immune system
This means the benefits come not just from new cells forming, but from the healing signals these cells send out to surrounding tissue.
Traditional Processing Methods Have Drawbacks
For years, doctors used enzymes and laboratory expansion to extract stem cells from fat tissue. While effective, these methods have significant limitations. The cells can age during extended laboratory processing. This aging reduces their ability to transform into different tissue types. These complex techniques also face strict regulations that make clinical use more difficult.
Lipogems® Preserves the Natural Healing Environment
Lipogems® technology was developed to address these challenges. The system gently processes fat tissue without enzymes or chemicals. It uses only washing and mild mechanical action to create tiny fat clusters about 0.3 to 0.8 millimeters in size. This preserves what scientists call the "stromal vascular niche," the natural support structure where healing cells live and function best.
Within this protected environment, special cells called pericytes remain attached to tiny blood vessels. When transferred to damaged tissue, these pericytes can become active stem cells and begin the healing process. This approach keeps the cells in their natural state, ready to work immediately.
Thousands of Patients Treated With Promising Results
At the time this review was published, more than 7,000 patients worldwide had received Lipogems® treatment. These procedures spanned aesthetic medicine, orthopedic surgery, and general surgery. The authors report remarkable and promising results with seemingly no drawbacks. The technology allows doctors to harvest, process, and inject refined fat tissue during a single procedure, eliminating the need for laboratory processing or multiple visits.
Clinical Trials Are Expanding the Evidence Base
The initial success of Lipogems® has led to multiple clinical trials designed to further document its benefits. These studies aim to provide stronger scientific support for what early patients have experienced. The technology represents a shift toward simpler, same-day regenerative treatments that use your own tissue without extensive manipulation.
For patients considering tissue regeneration options, this research highlights why fat-based treatments have gained popularity. The abundance of healing cells in fat tissue, combined with processing methods that preserve their natural function, offers a practical path to regenerative care. Lipogems® specifically addresses the limitations of older techniques while maintaining the rich healing potential that makes adipose tissue so valuable.
---
Source: Tremolada et al., Current Stem Cell Reports, 2016.
Original Publication
Adipose Tissue and Mesenchymal Stem Cells: State of the Art and Lipogems® Technology Development
Carlo Tremolada, Valeria Colombo, Carlo Ventura · Current Stem Cell Reports · 2016
In the past few years, interest in adipose tissue as an ideal source of mesenchymal stem cells (MSCs) has increased. These cells are multipotent and may differentiate in vitro into several cellular lineages, such as adipocytes, chondrocytes, osteoblasts, and myoblasts. In addition, they secrete many bioactive molecules and thus are considered "mini-drugstores." MSCs are being used increasingly for many clinical applications, such as orthopedic, plastic, and reconstructive surgery. Adipose-derived MSCs are routinely obtained enzymatically from fat lipoaspirate as SVF and/or may undergo prolonged ex vivo expansion, with significant senescence and a decrease in multipotency, leading to unsatisfactory clinical results. Moreover, these techniques are hampered by complex regulatory issues. Therefore, an innovative technique (Lipogems®; Lipogems International SpA, Milan, Italy) was developed to obtain microfragmented adipose tissue with an intact stromal vascular niche and MSCs with a high regenerative capacity. The Lipogems® technology, patented in 2010 and clinically available since 2013, is an easy-to-use system designed to harvest, process, and inject refined fat tissue and is characterized by optimal handling ability and a great regenerative potential based on adipose-derived MSCs. In the resulting Lipogems® product, pericytes are retained within an intact stromal vascular niche and are ready to interact with the recipient tissue after transplantation, thereby becoming MSCs and starting the regenerative process. Lipogems® has been used in more than 7000 patients worldwide in aesthetic medicine and surgery, as well as in orthopedic and general surgery, with remarkable and promising results.